CCK-58: A novel reagent for studying the regulation of cholecystokinin bioactivity
- 31 December 1996
- Vol. 17 (8), 1307-1311
- https://doi.org/10.1016/s0196-9781(96)00200-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogsGastroenterology, 1993
- Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumideDiabetologia, 1991
- Low immunoreactivity of canine cholecystokinin-58Gastroenterology, 1990
- Regulation of Pancreatic Endocrine Function by Cholecystokinin: Studies with MK-329, a Nonpeptide Cholecystokinin Receptor Antagonist*Journal of Clinical Endocrinology & Metabolism, 1990
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.JCI Insight, 1989
- Chemical characterization of rat cholecystokinin-58Peptides, 1988
- Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic aciniPeptides, 1986